Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination

Failure of remyelination is a critical impediment to recovery in multiple sclerosis (MS). Chondroitin sulfate proteoglycans (CSPGs) have been reported to accumulate in MS lesions, and we thus examined the functional roles of CSPGs on oligodendrocyte precursor cells (OPCs), oligodendrocytes, and remyelination.

[1]  Christine Stadelmann,et al.  Extensive Cortical Remyelination in Patients with Chronic Multiple Sclerosis , 2007, Brain pathology.

[2]  M. Simons,et al.  Actomyosin contractility controls cell surface area of oligodendrocytes , 2009, BMC Cell Biology.

[3]  M. Tuszynski,et al.  The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury , 2003, Experimental Neurology.

[4]  D. Osterhout,et al.  The inhibitory effects of chondroitin sulfate proteoglycans on oligodendrocytes , 2011, Journal of neurochemistry.

[5]  S. Weiss,et al.  Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate , 2009, Proceedings of the National Academy of Sciences.

[6]  P. Chambon,et al.  Retinoid X receptor gamma signaling accelerates CNS remyelination , 2011, Nature Neuroscience.

[7]  Robin J. M. Franklin,et al.  Remyelination in the CNS: from biology to therapy , 2008, Nature Reviews Neuroscience.

[8]  N. Schwartz.  Regulation of chondroitin sulfate synthesis. Effect of beta-xylosides on synthesis of chondroitin sulfate proteoglycan, chondroitin sulfate chains, and core protein. , 1977, The Journal of biological chemistry.

[9]  J. Newcombe,et al.  Extracellular Matrix in Multiple Sclerosis Lesions: Fibrillar Collagens, Biglycan and Decorin are Upregulated and Associated with Infiltrating Immune Cells , 2010, Brain pathology.

[10]  Voon Wee Yong,et al.  The good, the bad and the ugly. Macrophages/microglia with a focus on myelin repair. , 2011, Frontiers in bioscience.

[11]  Chao Zhao,et al.  Myelin Impairs CNS Remyelination by Inhibiting Oligodendrocyte Precursor Cell Differentiation , 2006, The Journal of Neuroscience.

[12]  J. Levine,et al.  Multiple Regions of the NG2 Proteoglycan Inhibit Neurite Growth and Induce Growth Cone Collapse , 2003, The Journal of Neuroscience.

[13]  R. Rudick,et al.  Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. , 2002, The New England journal of medicine.

[14]  U. Rauch.  Brain matrix: structure, turnover and necessity. , 2007, Biochemical Society transactions.

[15]  S. Back,et al.  A ‘GAG’ reflex prevents repair of the damaged CNS , 2008, Trends in Neurosciences.

[16]  R. Sobel,et al.  White Matter Extracellular Matrix Chondroitin Sulfate/Dermatan Sulfate Proteoglycans in Multiple Sclerosis , 2001, Journal of neuropathology and experimental neurology.

[17]  Hans Lassmann,et al.  Remyelination is extensive in a subset of multiple sclerosis patients. , 2006, Brain : a journal of neurology.

[18]  C. Bandtlow,et al.  Proteoglycans in the developing brain: new conceptual insights for old proteins. , 2000, Physiological reviews.

[19]  H. M. Geller,et al.  Inhibiting Glycosaminoglycan Chain Polymerization Decreases the Inhibitory Activity of Astrocyte-Derived Chondroitin Sulfate Proteoglycans , 2007, The Journal of Neuroscience.

[20]  S. Davies,et al.  Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin‐C during acute to chronic maturation of spinal cord scar tissue , 2003, Journal of neuroscience research.

[21]  C. ffrench-Constant,et al.  Laminin-2/Integrin Interactions Enhance Myelin Membrane Formation by Oligodendrocytes , 1999, Molecular and Cellular Neuroscience.

[22]  Mahendra S Rao,et al.  Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation , 2005, Nature Medicine.

[23]  F. Zipp,et al.  New insights into adaptive immunity in chronic neuroinflammation. , 2007, Advances in immunology.

[24]  Roland Martin,et al.  Multiple sclerosis: a complicated picture of autoimmunity , 2007, Nature Immunology.

[25]  B. Trapp,et al.  LINGO-1 negatively regulates myelination by oligodendrocytes , 2005, Nature Neuroscience.

[26]  C. Brosnan,et al.  Notch1 signaling plays a role in regulating precursor differentiation during CNS remyelination , 2009, Proceedings of the National Academy of Sciences.

[27]  G. Opdenakker,et al.  Matrix Metalloproteinase-9 Facilitates Remyelination in Part by Processing the Inhibitory NG2 Proteoglycan , 2003, The Journal of Neuroscience.

[28]  R. Franklin,et al.  Rejuvenation of regeneration in the aging central nervous system. , 2012, Cell stem cell.

[29]  H. Watanabe,et al.  Roles of aggrecan, a large chondroitin sulfate proteoglycan, in cartilage structure and function. , 1998, Journal of biochemistry.

[30]  M. Schwartz,et al.  The Glial Scar-Monocyte Interplay: A Pivotal Resolution Phase in Spinal Cord Repair , 2011, PloS one.

[31]  D. Stelzner,et al.  Chondroitinase treatment following spinal contusion injury increases migration of oligodendrocyte progenitor cells , 2011, Experimental Neurology.

[32]  Michal Schwartz,et al.  America , 2012 .

[33]  Barbara Grimpe,et al.  A Novel DNA Enzyme Reduces Glycosaminoglycan Chains in the Glial Scar and Allows Microtransplanted Dorsal Root Ganglia Axons to Regenerate beyond Lesions in the Spinal Cord , 2004, The Journal of Neuroscience.

[34]  C. Wegner,et al.  Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. , 2008, Brain : a journal of neurology.

[35]  A. Caplan,et al.  The effects of beta-D-xyloside on the synthesis of proteoglycans by skeletal muscle: lack of effect on decorin and differential polymerization of core protein-bound and xyloside-linked chondroitin sulfate. , 1994, Matrix biology : journal of the International Society for Matrix Biology.

[36]  J. Sloane,et al.  Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2 , 2010, Proceedings of the National Academy of Sciences.

[37]  W. Brück,et al.  Remyelination capacity of the MS brain decreases with disease chronicity , 2009, Neurology.

[38]  D. Rowitch,et al.  Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. , 2009, Genes & development.

[39]  James W. Fawcett,et al.  Chondroitinase ABC promotes functional recovery after spinal cord injury , 2002, Nature.

[40]  David H Rowitch,et al.  Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination , 2010, Annals of neurology.

[41]  S. Weiss,et al.  White Matter Plasticity and Enhanced Remyelination in the Maternal CNS , 2007, The Journal of Neuroscience.

[42]  Jerry Silver,et al.  Regeneration beyond the glial scar , 2004, Nature Reviews Neuroscience.

[43]  E. Frohman,et al.  Multiple sclerosis--the plaque and its pathogenesis. , 2006, The New England journal of medicine.